To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound - Lamuraglia, M; Escudier, B; Chami, L (Eur J Cancer, 2006)
et al.